Injection of immunoglobulin in the treatment process of children with severe pneumonia: Treatment of children with severe pneumonia

Objective: To observe the effect of intravenous infusion of immune globulin in the treatment of children with severe pneumonia. Methods: Ninety-eight children with severe pneumonia who received treatment in our hospital between April 2015 and December 2016 were selected, and they were grouped into a control group and an treatment group, 49 each group. The control group received conventional treatment. The treatment group was additionally treated with immune globulin on the basis of conventional treatment. The humoral immune indicators were detected using immunoturbidimetric assay, and the inflammatory reaction indicators were detected using enzyme-linked immunoabsorbent kit. The overall efficacy, clinical symptoms, humoral immunity and inflammatory response were compared between the two groups. Results: The total effective rate of the treatment group was significantly higher than that of the control group (P0.05) before treatment, but the content of the treatment group was significantly higher than that of the control group (P